课题基金 / 基金详情

IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2

IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2
IMAGINE(炎症、微生物组和营养:胃肠道和神经精神影响)SPOR 慢性病网络 - 知识动员
批准号:
459699
负责人:
Moayyedi Paul
金额:
$272.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Directed Grant
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-12-01 至 2025-12-01

项目摘要

项目成果

Moayyedi Paul的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Canada has the highest rates of Inflammatory bowel disease (IBD) (consisting of ulcerative colitis (UC) and Crohn's disease) in the world, affecting 0.5 million Canadians. Irritable bowel syndrome (IBS) affects 2 million Canadians. The cause of IBD and IB
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE-SPOR chronic disease network.
  • 批准号:
    337906
  • 项目类别:
    Operating Grants
  • 资助金额:
    $906.98万
  • 财政年份:
    2015
  • 负责人:
    Moayyedi Paul
  • 依托单位:
Microbiota INteracting with Diet as a therapeutic strategy in GastroIntestinal and psychiatric disease: The MIND GI SPOR network.
  • 批准号:
    323909
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.6万
  • 财政年份:
    2015
  • 负责人:
    Moayyedi Paul
  • 依托单位:
Developing a tool for determining risk of peptic ulcer complications with non-steroidal anti-inflammatory drugs.
  • 批准号:
    230303
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.27万
  • 财政年份:
    2011
  • 负责人:
    Moayyedi Paul
  • 依托单位:
海外基金